UBS Group »

Silexion Therapeutics Corp shares owned by UBS Group

Quarter-by-quarter ownership of Silexion Therapeutics Corp (SLXN) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Silexion Therapeutics Corp

Tip: Access up to 7 years of quarterly data

All positions including Silexion Therapeutics Corp held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Silexion Therapeutics Corp by UBS Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $2.4k 692 3.40

More positions owned by UBS Group

Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Amazon (AMZN)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
JPMorgan Chase & Co. (JPM)
Alphabet Cap Stk Cl C (GOOG)
Ubs Group SHS (UBS)
Tesla Motors (TSLA)
Ishares Tr Russell 2000 Etf (IWM)
Visa Com Cl A (V)

View all positions for UBS Group

Top funds holding Silexion Therapeutics Corp

A. Montag and Associates
SBI Securities
UBS Group
Pflug Koory

View all funds holding Silexion Therapeutics Corp